18
Jun
"....Last week’s ruling was widely expected, legal experts say. “Anybody that values reproductive freedom and the scientific integrity of the [U.S. Food and Drug Administration] can breathe a sigh of relief,” says Lawrence Gostin, a professor of global health law at Georgetown University. But “it would be foolish to declare victory” for abortion rights, he says. The ruling was a narrow legal technicality that didn’t go into the case’s actual merits. It’s quite possible, Gostin says, that the Court could make future rulings that restrict access to medication abortion and usurp the FDA’s broader authority to regulate drug safety...."